Coco Chengliang Dong

Cited by

	All	Since 2019
Citations	1812	1348
h-index	8	8
i10-index	8	7

280

140

210

201520162017201820192020202120222023202426 84 142 198 251 250 278 266 222 81

Public access

View all

7 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Kai WangChildren's Hospital of PhiladelphiaVerified email at email.chop.edu
Xiaoming LiuAssociate Professor, College of Public Health, University of South FloridaVerified email at usf.edu
Peng WeiProfessor, The University of Texas MD Anderson Cancer CenterVerified email at mdanderson.org
Congzheng SongApple Inc.Verified email at apple.com
Lee CooperDepartment of Pathology, Northwestern UniversityVerified email at northwestern.edu
Safoora YousefiMicrosoftVerified email at microsoft.com
Mohamed Amgad TageldinDept. of Pathology, Northwestern UniversityVerified email at northwestern.edu
Sameer H. HalaniUT-SouthwesternVerified email at phhs.org
David GutmanAssistant Professor of Neurology, Psychiatry, Biomedical Informatics, Emory UniversityVerified email at emory.edu
Daniel J BratDepartment of Pathology, Northwestern University Feinberg School of MedicineVerified email at northwestern.edu
Gangcai XieProfessor, Nantong UniversityVerified email at ntu.edu.cn
Yinfei KongAssociate Professor, College of Business & Economics, California State University FullertonVerified email at fullerton.edu
Yunfei GuoRoche Sequencing SolutionsVerified email at roche.com
Yufeng ShenAssociate Professor, Columbia UniversityVerified email at cumc.columbia.edu
Wendy ChungBoston Children's Hospital, Harvard Medical SchoolVerified email at cumc.columbia.edu
Mugdha KhaladkarComputational Biologist, GSKVerified email at gsk.com
Sarah A. MiddletonGSKVerified email at gsk.com
Euan StronachGSKVerified email at gsk.com
Hui YangUniversity of Southern CaliforniaVerified email at usc.edu

Coco Chengliang Dong

Deerfield Management

Verified email at usc.edu - Homepage

Machine learning Cancer Genomics


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies C Dong, P Wei, X Jian, R Gibbs, E Boerwinkle, K Wang, X Liu Human molecular genetics 24 (8), 2125-2137, 2015	1083	2015
Long-read sequencing and de novo assembly of a Chinese genome L Shi, Y Guo, C Dong, J Huddleston, H Yang, X Han, A Fu, Q Li, N Li, ... Nature communications 7 (1), 12065, 2016	282	2016
Predicting clinical outcomes from large scale cancer genomic profiles with deep survival models S Yousefi, F Amrollahi, M Amgad, C Dong, JE Lewis, C Song, DA Gutman, ... Scientific reports 7 (1), 1-11, 2017	223	2017
Group lasso regularized deep learning for cancer prognosis from multi-omics and clinical features G Xie, C Dong, Y Kong, JF Zhong, M Li, K Wang Genes 10 (3), 240, 2019	66	2019
iCAGES: integrated CAncer GEnome Score for comprehensively prioritizing driver genes in personal cancer genomes C Dong, Y Guo, H Yang, Z He, X Liu, K Wang Genome medicine 8, 1-22, 2016	48	2016
Excess of rare variants in genes that are key epigenetic regulators of spermatogenesis in the patients with non-obstructive azoospermia Z Li, Y Huang, H Li, J Hu, X Liu, T Jiang, G Sun, A Tang, X Sun, W Qian, ... Scientific reports 5 (1), 8785, 2015	47	2015
Deep genetic connection between cancer and developmental disorders H Qi, C Dong, WK Chung, K Wang, Y Shen Human mutation 37 (10), 1042-1050, 2016	32	2016
Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes X Zhang, H Jia, Y Lu, C Dong, J Hou, Z Wang, F Wang, H Zhong, L Wang, ... Discovery medicine 18 (101), 301, 2014	24	2014
Refining the impact of genetic evidence on clinical success EV Minikel, JL Painter, CC Dong, MR Nelson Nature, 1-6, 2024	7	2024
Identification of novel cancer target genes by combining data from the cancer genome-wide association studies (GWAS), regulatory DNA elements and The Cancer Genome Atlas (TCGA) DA Kulkarni, K Guo, J Jing, M Khaladkar, K Song, C Dong, D Cooper, ... Cancer Research 78 (13_Supplement), 236-236, 2018		2018
Identification and validation of synthetic lethal cancer pairs from genome-wide CRISPR screens B Schwartz, J Jing, E Stronach, D Cooper, B Wilson, S Middleton, ... Cancer Research 78 (13_Supplement), 2344-2344, 2018		2018
Statistical methods for cancer genome analysis C Dong University of Southern California, 2016		2016

The system can't perform the operation now. Try again later.

Articles 1–12

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors